123 related articles for article (PubMed ID: 26069331)
1. Time to tune the treatment of Ph+ ALL.
Yanada M
Blood; 2015 Jun; 125(24):3674-5. PubMed ID: 26069331
[TBL] [Abstract][Full Text] [Related]
2. Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.
Chalandon Y; Thomas X; Hayette S; Cayuela JM; Abbal C; Huguet F; Raffoux E; Leguay T; Rousselot P; Lepretre S; Escoffre-Barbe M; Maury S; Berthon C; Tavernier E; Lambert JF; Lafage-Pochitaloff M; Lhéritier V; Chevret S; Ifrah N; Dombret H;
Blood; 2015 Jun; 125(24):3711-9. PubMed ID: 25878120
[TBL] [Abstract][Full Text] [Related]
3. Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era.
Shimizu H; Yokohama A; Hatsumi N; Takada S; Handa H; Sakura T; Nojima Y
Eur J Haematol; 2014 Oct; 93(4):297-301. PubMed ID: 24750307
[TBL] [Abstract][Full Text] [Related]
4. [Molecular response and prognostic factors of patients with Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia treated by imatinib with chemotherapy].
Wang J; Huang X; Jiang B; Qin Y; Bao L; Jiang H; Chen H; Jia J; Yang S; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):120-5. PubMed ID: 24606652
[TBL] [Abstract][Full Text] [Related]
5. [Imatinib in combination with allogeneic hematopoietic stem cell transplantation improved the outcome of adult Philadelphia chromosome-positive acute lymphoblastic leukemia].
Cheng Z; Zhao L; Chen G; Wu D; Qiu H; Tang X; Fu C; Jin Z; Chen F; Xue S; Sun A
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):114-9. PubMed ID: 24606651
[TBL] [Abstract][Full Text] [Related]
6. Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).
Ottmann OG; Wassmann B; Pfeifer H; Giagounidis A; Stelljes M; Dührsen U; Schmalzing M; Wunderle L; Binckebanck A; Hoelzer D;
Cancer; 2007 May; 109(10):2068-76. PubMed ID: 17429836
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic significance of Ph-positive acute lymphoblastic leukemia].
Zhou L; Hu J; Chen J; Du S; Wang A; You J; Wu W; Shen Z; Li J
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):109-13. PubMed ID: 24606650
[TBL] [Abstract][Full Text] [Related]
8. Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
Ottmann OG; Pfeifer H
Hematology Am Soc Hematol Educ Program; 2009; ():371-81. PubMed ID: 20008223
[TBL] [Abstract][Full Text] [Related]
9. [Outcome of autologous hematopoietic stem cell transplantation in combination with imatinib for 16 cases of Philadelphia chromosome positive acute lymphoblastic leukemia].
Liu X; Jiang E; Huang Y; Yang D; Pang A; Wei J; Ma Q; Zhang R; Qiu L; Feng S; Han M
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):250-2. PubMed ID: 24666497
[No Abstract] [Full Text] [Related]
10. Long-term imatinib maintenance therapy for adult Philadelphia positive acute lymphoblastic leukemia.
Guillet S; Hirsch P; Marzac C; Mohty M; Marie JP; Legrand O
Leuk Lymphoma; 2014 Nov; 55(11):2646-8. PubMed ID: 24491028
[No Abstract] [Full Text] [Related]
11. Treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
Thomas X; Dombret H
Leuk Lymphoma; 2008 Jul; 49(7):1246-54. PubMed ID: 18452076
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031.
Schultz KR; Carroll A; Heerema NA; Bowman WP; Aledo A; Slayton WB; Sather H; Devidas M; Zheng HW; Davies SM; Gaynon PS; Trigg M; Rutledge R; Jorstad D; Winick N; Borowitz MJ; Hunger SP; Carroll WL; Camitta B;
Leukemia; 2014 Jul; 28(7):1467-71. PubMed ID: 24441288
[TBL] [Abstract][Full Text] [Related]
13. Childhood Philadelphia-chromosome-positive B-lymphoblastic leukaemia.
Thomas D
Lancet Oncol; 2012 Sep; 13(9):860-2. PubMed ID: 22935232
[No Abstract] [Full Text] [Related]
14. Imatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia: a viewpoint by Joseph Brandwein.
Brandwein J
Drugs; 2007; 67(17):2655. PubMed ID: 18034600
[No Abstract] [Full Text] [Related]
15. Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement.
Soverini S; De Benedittis C; Papayannidis C; Paolini S; Venturi C; Iacobucci I; Luppi M; Bresciani P; Salvucci M; Russo D; Sica S; Orlandi E; Intermesoli T; Gozzini A; Bonifacio M; Rigolin GM; Pane F; Baccarani M; Cavo M; Martinelli G
Cancer; 2014 Apr; 120(7):1002-9. PubMed ID: 24382642
[TBL] [Abstract][Full Text] [Related]
16. Imatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia: a viewpoint by Barbara Wassmann.
Wassmann B
Drugs; 2007; 67(17):2656. PubMed ID: 18034598
[No Abstract] [Full Text] [Related]
17. Possible alternative strategy for stage I imatinib-sensitive testicular seminoma; lessons from a case associated with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Okamura A; Wakahashi K; Ishii S; Katayama Y; Yamamoto K; Matsui T
Ann Oncol; 2010 May; 21(5):1129-30. PubMed ID: 20080832
[No Abstract] [Full Text] [Related]
18. Imatinib for secondary Ph+ acute lymphoblastic leukemia induces response in concomitant GBM.
De Vita S; De Matteis S; Laurenti L; Chiusolo P; Sorà F; Piccirillo N; Reddiconto G; Fiorini A; Leone G; Sica S
Ann Oncol; 2006 Apr; 17(4):720-1. PubMed ID: 16263757
[No Abstract] [Full Text] [Related]
19. Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Gruber F; Mustjoki S; Porkka K
Br J Haematol; 2009 Jun; 145(5):581-97. PubMed ID: 19388927
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment with imatinib combined with less intensive chemotherapy (vincristine and dexamethasone) as induction therapy in a very elderly patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Nishii K; Sakakura M; Tsukada T; Ryuu H; Katayama N
Int J Hematol; 2007 Apr; 85(3):273-4. PubMed ID: 17483068
[No Abstract] [Full Text] [Related]
[Next] [New Search]